Results 131 to 140 of about 16,351 (268)

Perlecan and synaptophysin changes in denervated skeletal muscle.

open access: yesNeural regeneration research, 2012
The present study observed sciatic nerve and gastrocnemius muscle changes in denervated rats using morphology methods, and assessed expression of perlecan, an extracellular matrix component, which is located at the skeletal muscle cell surface as acetylcholine esterase, as well as synaptophysin, a synaptic marker.
Huiming Wang   +5 more
openaire   +3 more sources

Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy [PDF]

open access: yes, 2013
OBJECTIVE: Sulodexide is a mixture of glycosaminoglycans that may reduce proteinuria in diabetic nephropathy (DN), but its mechanism of action and effect on renal histology is not known. We investigated the effect of sulodexide on disease manifestations
Chan, DTM   +4 more
core   +1 more source

Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer

open access: yesScientific Reports, 2019
In recent years, there have been significant advances in the treatment of breast cancer resulting in remarkably high survival rates. However, treatment options for metastatic triple negative breast cancer (TNBC) are quite limited due to a lack of ...
Stephen Kalscheuer   +7 more
semanticscholar   +1 more source

The developmental roles of the extracellular matrix: Beyond structure to regulation [PDF]

open access: yes, 2010
Cells in multicellular organisms are surrounded by a complex three-dimensional macromolecular extracellular matrix (ECM). This matrix, traditionally thought to serve a structural function providing support and strength to cells within tissues, is ...
Chan, D   +3 more
core   +1 more source

Pathogenesis of abdominal aortic aneurysms: Possible role of differential production of proteoglycans by smooth muscle cells [PDF]

open access: yes, 1998
Purpose: In vivo and in vitro observations strongly suggest that marked differences exist in the phenotype, growth, and matrix-producing capabilities of distinct smooth muscle cell subpopulations.
Ghosh, Peter   +3 more
core   +1 more source

Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer

open access: yesFuture Drug Discovery, 2019
Aim: We previously developed two antibodies that bind to a cell surface protein, perlecan, overexpressed in triple-negative breast cancer (TNBC). The goal of this study was to investigate these antibodies as targeting ligands for nanoparticle-mediated ...
Vidhi Khanna   +4 more
semanticscholar   +1 more source

Dynamic regulation of basement membrane protein levels promotes egg chamber elongation in Drosophila [PDF]

open access: yes, 2015
Basement membranes (BMs) are sheet-like extracellular matrices that provide essential support to epithelial tissues. Recent evidence suggests that regulated changes in BM architecture can direct tissue morphogenesis, but the mechanisms by which cells ...
Horne-Badovinac, Sally   +1 more
core   +1 more source

Perlecan, a heparan sulfate proteoglycan, regulates systemic metabolism with dynamic changes in adipose tissue and skeletal muscle

open access: yesScientific Reports, 2018
Perlecan (HSPG2), a heparan sulfate proteoglycan, is a component of basement membranes and participates in a variety of biological activities. Here, we show physiological roles of perlecan in both obesity and the onset of metabolic syndrome.
Y. Yamashita   +7 more
semanticscholar   +1 more source

Extracellular matrix and nuclear abnormalities in skeletal muscle of a patient with Walker–Warburg syndrome caused by POMT1 mutation [PDF]

open access: yes, 2003
Walker–Warburg syndrome (WWS) is an autosomal recessive disorder characterized by congenital muscular dystrophy, structural eye abnormalities and severe brain malformations.
Sabatelli, Patrizia   +9 more
core   +6 more sources

Extracellular Matrix Molecules Facilitating Vascular Biointegration

open access: yesJournal of Functional Biomaterials, 2012
All vascular implants, including stents, heart valves and graft materials exhibit suboptimal biocompatibility that significantly reduces their clinical efficacy.
Martin K.C. Ng   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy